Cargando…
Glenzocimab does not impact glycoprotein VI-dependent inflammatory hemostasis
Autores principales: | Jadoui, Soumaya, Le Chapelain, Ophélie, Ollivier, Véronique, Mostefa-Kara, Ali, Di Meglio, Lucas, Dupont, Sébastien, Gros, Angèle, Nomenjanahary, Mialitiana Solo, Desilles, Jean-Philippe, Mazighi, Mikaël, Nieswandt, Bernhard, Loyau, Stéphane, Jandrot-Perrus, Martine, Mangin, Pierre H., Ho-Tin-Noé, Benoit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252939/ https://www.ncbi.nlm.nih.gov/pubmed/33375772 http://dx.doi.org/10.3324/haematol.2020.270439 |
Ejemplares similares
-
Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition
por: Billiald, Philippe, et al.
Publicado: (2022) -
Collagen Can Selectively Trigger a Platelet Secretory Phenotype via Glycoprotein VI
por: Ollivier, Véronique, et al.
Publicado: (2014) -
Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet Aggregation
por: Renaud, Lionel, et al.
Publicado: (2020) -
Downstream Microvascular Thrombosis in Cortical Venules Is an Early Response to Proximal Cerebral Arterial Occlusion
por: Desilles, Jean‐Philippe, et al.
Publicado: (2018) -
Modeling Large Vessel Occlusion Stroke for the Evaluation of Endovascular Therapy According to Thrombus Composition
por: Freiherr von Seckendorff, Aurélien, et al.
Publicado: (2022)